News
BXPHF
0.076
NaN%
--
Weekly Report: what happened at BXPHF last week (0908-0912)?
Weekly Report · 09/15 12:01
Weekly Report: what happened at BXPHF last week (0901-0905)?
Weekly Report · 09/08 12:02
Weekly Report: what happened at BXPHF last week (0825-0829)?
Weekly Report · 09/01 11:56
Weekly Report: what happened at BXPHF last week (0818-0822)?
Weekly Report · 08/25 12:12
Weekly Report: what happened at BXPHF last week (0811-0815)?
Weekly Report · 08/18 12:00
Weekly Report: what happened at BXPHF last week (0804-0808)?
Weekly Report · 08/11 12:10
Weekly Report: what happened at BXPHF last week (0728-0801)?
Weekly Report · 08/04 12:13
Weekly Report: what happened at BXPHF last week (0721-0725)?
Weekly Report · 07/28 12:14
Weekly Report: what happened at BXPHF last week (0714-0718)?
Weekly Report · 07/21 12:01
Weekly Report: what happened at BXPHF last week (0707-0711)?
Weekly Report · 07/14 12:14
Weekly Report: what happened at BXPHF last week (0630-0704)?
Weekly Report · 07/07 12:02
Weekly Report: what happened at BXPHF last week (0623-0627)?
Weekly Report · 06/30 12:11
Weekly Report: what happened at BXPHF last week (0616-0620)?
Weekly Report · 06/23 12:00
Weekly Report: what happened at BXPHF last week (0609-0613)?
Weekly Report · 06/16 12:10
Weekly Report: what happened at BXPHF last week (0602-0606)?
Weekly Report · 06/09 12:12
Weekly Report: what happened at BXPHF last week (0526-0530)?
Weekly Report · 06/02 12:24
Weekly Report: what happened at BXPHF last week (0519-0523)?
Weekly Report · 05/26 12:23
Weekly Report: what happened at BXPHF last week (0512-0516)?
Weekly Report · 05/19 12:10
Weekly Report: what happened at BXPHF last week (0505-0509)?
Weekly Report · 05/12 12:10
Weekly Report: what happened at BXPHF last week (0428-0502)?
Weekly Report · 05/05 12:13
More
Webull provides a variety of real-time BXPHF stock news. You can receive the latest news about Botanix Pharma through multiple platforms. This information may help you make smarter investment decisions.
About BXPHF
Botanix Pharmaceuticals Limited is an Australia-based dermatology company. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).